{"transactions":[{"id":4637626,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-08T01:00:13.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted this option pursuant to the 2026 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2027 annual meeting of stockholders or October 5, 2027."}],"balance_after":64000,"derivative":{"exercise_price":3.75,"expiration_date":"2036-10-05","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001193125-26-417237","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526417237/ownership.xml","form_type":"4"}},{"id":4637625,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-08T01:00:13.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":10700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted stock unit award (RSU) pursuant to the 2026 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2027 annual meeting of stockholders or October 5, 2027."}],"balance_after":200917,"source":{"system":"sec-edgar","filing":"0001193125-26-417237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526417237/ownership.xml","form_type":"4"}},{"id":974043,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-10T21:45:09.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":7980,"price":14.05,"value":112119.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $13.75 to $14.70 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price"}],"balance_after":275217,"source":{"system":"sec-edgar","filing":"0001193125-25-314738","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000119312525314738/ownership.xml","form_type":"4"}},{"id":974042,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-10T21:45:09.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":12020,"price":13.09,"value":157341.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $12.75 to $13.74 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":283197,"source":{"system":"sec-edgar","filing":"0001193125-25-314738","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000119312525314738/ownership.xml","form_type":"4"}},{"id":1055383,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-26T21:40:05.000Z","date":"2025-08-22","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":10,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":285217,"source":{"system":"sec-edgar","filing":"0000950170-25-111568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000095017025111568/ownership.xml","form_type":"4"}},{"id":1067525,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-08-13T20:00:06.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":76200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted this option pursuant to the 2025 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026."}],"balance_after":76200,"derivative":{"exercise_price":8.105,"expiration_date":"2030-08-11","underlying":"Ordinary Shares","underlying_shares":76200},"source":{"system":"sec-edgar","filing":"0000950170-25-108285","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000095017025108285/ownership.xml","form_type":"4"}},{"id":1067524,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-13T20:00:06.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":12700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted share unit award (RSU) pursuant to the 2025 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026."}],"balance_after":295217,"source":{"system":"sec-edgar","filing":"0000950170-25-108285","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000095017025108285/ownership.xml","form_type":"4"}},{"id":1111053,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-13T20:00:04.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":6.95,"value":208500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $6.79 to $7.04 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":282517,"source":{"system":"sec-edgar","filing":"0000950170-25-086466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000095017025086466/ownership.xml","form_type":"4"}},{"id":1216871,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-03-07T21:00:05.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":133402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The share options that were exercised via cash purchase in this reportable transaction were fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":133402},"source":{"system":"sec-edgar","filing":"0000950170-25-035834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000095017025035834/ownership.xml","form_type":"4"}},{"id":1216870,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-03-07T21:00:05.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":false,"shares":133000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The share options that were exercised via cash purchase in this reportable transaction were fully vested."}],"balance_after":133402,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":133000},"source":{"system":"sec-edgar","filing":"0000950170-25-035834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000095017025035834/ownership.xml","form_type":"4"}},{"id":1216869,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-03-07T21:00:05.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":133402,"price":2.48,"value":330836.96,"ownership":{"direct":true},"balance_after":312517,"source":{"system":"sec-edgar","filing":"0000950170-25-035834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000095017025035834/ownership.xml","form_type":"4"}},{"id":1216868,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-03-07T21:00:05.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":true,"shares":133000,"price":2.48,"value":329840.0,"ownership":{"direct":true},"balance_after":179155,"source":{"system":"sec-edgar","filing":"0000950170-25-035834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000095017025035834/ownership.xml","form_type":"4"}},{"id":1433358,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2024-08-14T18:00:05.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":32230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted this option pursuant to the 2024 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025."}],"balance_after":32230,"derivative":{"exercise_price":5.37,"expiration_date":"2029-08-12","underlying":"Ordinary Shares","underlying_shares":32230},"source":{"system":"sec-edgar","filing":"0000950170-24-097285","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000095017024097285/ownership.xml","form_type":"4"}},{"id":1433357,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-14T18:00:05.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":16115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted share unit award (RSU) pursuant to the 2024 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025."}],"balance_after":46115,"source":{"system":"sec-edgar","filing":"0000950170-24-097285","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000095017024097285/ownership.xml","form_type":"4"}},{"id":1811707,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2023-08-09T20:00:14.000Z","date":"2023-08-07","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2024 annual general meeting or August 7, 2024."}],"balance_after":45000,"derivative":{"exercise_price":4.58,"expiration_date":"2028-08-07","underlying":"Ordinary Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-23-017910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924323017910/doc4.xml","form_type":"4"}},{"id":2130219,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2022-10-28T20:00:13.000Z","date":"2022-10-27","kind":"grant","acquired":true,"shares":163467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to his existing consulting agreement with Wave. The option vests in equal monthly installments beginning on October 31, 2022, through December 31, 2024, subject to the reporting person's continued services through the applicable vesting date."}],"balance_after":163467,"derivative":{"exercise_price":4.37,"expiration_date":"2027-10-27","underlying":"Ordinary Shares","underlying_shares":163467},"source":{"system":"sec-edgar","filing":"0000899243-22-034493","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924322034493/doc4.xml","form_type":"4"}},{"id":2180716,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2022-08-17T20:01:13.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2023 annual general meeting or August 15, 2023."}],"balance_after":21000,"derivative":{"exercise_price":3.5,"expiration_date":"2027-08-15","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-22-029098","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924322029098/doc4.xml","form_type":"4"}},{"id":2597331,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2021-08-18T18:12:00.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 12.5% of the shares in equal quarterly installments over the two-year period following the grant date on August 16, 2021."}],"balance_after":42000,"derivative":{"exercise_price":5.97,"expiration_date":"2026-08-16","underlying":"Ordinary Shares","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0000899243-21-033528","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924321033528/doc4.xml","form_type":"4"}},{"id":3050724,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2020-08-20T18:34:47.000Z","date":"2020-08-18","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2021 annual general meeting or August 18, 2021."}],"balance_after":10500,"derivative":{"exercise_price":9.13,"expiration_date":"2025-08-18","underlying":"Ordinary Shares","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000899243-20-023089","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924320023089/doc4.xml","form_type":"4"}},{"id":3360803,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-11-22T17:49:23.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":2609,"price":32.74,"value":85418.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $32.69 to $32.76 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0000899243-19-027985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924319027985/doc4.xml","form_type":"4"}},{"id":3360802,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-11-22T17:49:23.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":3400,"price":31.59,"value":107406.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $31.50 to $32.04 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":32609,"source":{"system":"sec-edgar","filing":"0000899243-19-027985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924319027985/doc4.xml","form_type":"4"}},{"id":3360801,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-11-22T17:49:23.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":24030,"price":30.27,"value":727388.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $30.07 to $31.045 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":36009,"source":{"system":"sec-edgar","filing":"0000899243-19-027985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924319027985/doc4.xml","form_type":"4"}},{"id":3435770,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2019-08-16T16:22:04.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2020 annual general meeting or August 15, 2020."}],"balance_after":10500,"derivative":{"exercise_price":20.34,"expiration_date":"2024-08-15","underlying":"Ordinary Shares","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000899243-19-021967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924319021967/doc4.xml","form_type":"4"}},{"id":3760594,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-11-16T17:15:18.000Z","date":"2018-11-14","kind":"sale","acquired":false,"shares":4300,"price":39.52,"value":169936.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $39.33 to $39.53 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.."}],"balance_after":60039,"source":{"system":"sec-edgar","filing":"0000899243-18-029157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924318029157/doc4.xml","form_type":"4"}},{"id":3760593,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-11-16T17:15:18.000Z","date":"2018-11-14","kind":"sale","acquired":false,"shares":10700,"price":38.59,"value":412913.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $38.15 to $39.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":64339,"source":{"system":"sec-edgar","filing":"0000899243-18-029157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924318029157/doc4.xml","form_type":"4"}},{"id":3843028,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2018-08-15T20:09:11.000Z","date":"2018-08-13","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on August 13, 2019."}],"balance_after":9000,"derivative":{"exercise_price":46.7,"expiration_date":"2023-08-13","underlying":"Ordinary Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-18-022513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924318022513/doc4.xml","form_type":"4"}},{"id":4057150,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-02-14T19:07:21.000Z","date":"2017-08-07","kind":"gift","acquired":false,"shares":75040,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75039,"source":{"system":"sec-edgar","filing":"0000899243-18-003953","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924318003953/doc5.xml","form_type":"5"}},{"id":4230250,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2017-08-17T16:19:10.000Z","date":"2017-08-10","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on August 10, 2018."}],"balance_after":9000,"derivative":{"exercise_price":18.1,"expiration_date":"2022-08-10","underlying":"Ordinary Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-17-020601","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924317020601/doc4.xml","form_type":"4"}},{"id":4557170,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":71888,"kind":"person","name":"Verdine Gregory L.","position":1,"cik":"0001572315","reported_name":"Verdine Gregory L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2016-11-14T17:41:52.000Z","date":"2016-11-10","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on November 10, 2017."}],"balance_after":9000,"derivative":{"exercise_price":36.43,"expiration_date":"2021-11-10","underlying":"Ordinary Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-16-033354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572315/000089924316033354/doc4.xml","form_type":"4"}}]}